Vivo Bio Tech Limited (BOM:511509)

Market Cap	686.10M
Revenue (ttm)	461.40M
Net Income (ttm)	69.56M
Shares Out	17.48M
EPS (ttm)	4.16
PE Ratio	9.44
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,770
Average Volume	37,278
Open	40.01
Previous Close	40.00
Day's Range	38.45 - 40.49
52-Week Range	31.20 - 56.90
Beta	0.67
RSI	56.40
Earnings Date	May 20, 2025

About Vivo Bio Tech

Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, and analytical services. It also supplies SPF lab animals; breeds and distributes rodent models; and offers custom rodent models, and stem cell products, as well as lab animal diets. In addition, the company provides regulatory and non-regulatory...

• Industry: Commercial Physical and Biological Research
• Founded: 1987
• Employees: 161
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 511509

Financial Performance

In 2023, Vivo Bio Tech's revenue was 454.51 million, a decrease of -12.98% compared to the previous year's 522.30 million. Earnings were 25.26 million, a decrease of -4.64%.